Life Science Investing Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
Life Science Investing Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025
Life Science Investing Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
RZOLV Technologies Appoints Mary Ellen Thorburn to the Board of Directors; Announces the Retirement of Darryl Yea
